BioAesthetics
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- bio-aesthetics.com
- Last Round
- Series AOct 2020
- Rounds
- 2
About
BioAesthetics is a Tulane University spinout developing next-generation breast implants using bioresorbable polymer scaffolds seeded with autologous fat tissue for breast cancer reconstruction patients. Founded in 2015, the company aims to provide safer and more natural alternatives to traditional silicone implants. Its technology is designed to bioresorb over time as the body's own tissue regenerates.
Summary
BioAesthetics is a Biotech company, founded in 2015. Its most recent funding was a Series A round in Oct 2020. Investors include Joyance Partners, Arizona Tech Investors and IndieBio.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...